Previous News
•10/2021: Our collaborative paper with Schedin lab was accepted to PNAS!
•09/2021: A collaborative paper was accepted to Cancer Discovery!
•08/2021: Duanchen’s bioinformatics method SCISSOR for phenotype-guided cell subpopulation identification from single-cell data was accepted to Nature Biotechnology! Congratulations!
•08/2021: Ya-Mei joined our lab as a Postdoctoral Researcher. Welcome!
•08/2021: Duanchen and Wes's study about young women's breast cancer was accepted to Nature Communications. Cheers!
•05/2021: Duanchen's paper about blocking prostate cancer lineage plasticity through BET Bromodomain inhibition was accepted to Clinical Cancer Research! Congratulations!
•02/2021: A new grant was awarded to the Xia Lab: Established Investigator Idea Development Award from the Department of Defense Prostate Cancer Research Program!
•11/2020: Our collaboration with Dr. Alexey Danilov was funded by an R01 (scored at 2%) to study the mechanisms underlying the drug resistance in Mantle cell lymphoma!
•09/2020: Guan has accepted the offer from Genentech as an associate scientist in Bioinformatics. Good experimental biologists have the intrinsic properties to become good computational biologists!
•08/2020: A collaborative R01 with Dr. Alumkal was funded (scored at 2%). We are looking forward to working with Alumkal lab to target prostate cancer lineage plasticity!
•06/2020: Guan's paper about copy number loss in enzalutamide-resistant prostate cancer was accepted to Clinical Cancer Research! Congratulations!
•04/2020: Our paper about enzalutamide-resistant prostate cancer was accepted by PNAS!
•03/2020: Guan received a travel award to present at the Thirteenth Annual Prostate Cancer Program Retreat in Florida.
•02/2020: Our collaborative work in single-cell RNA-seq data analysis of tendon cells was published in eLife!
•11/2019: Our paper is accepted to BMC Medical Genomics. Congratulations!
•11/2019: Our research is funded by the The Medical Research Foundation of Oregon!
•08/2019: We are awarded a NIH R21 grant to study the alternative polyadenylation in immune cells. Congratulations!
•05/2019: Guan's poster was selected into the discussion session at ASCO. Great job!
•02/2019: Chaojie has obtained his dream job at Bristol-Myers Squibb as a bioinformatics scientist in cancer immunotherapy research. Good luck!
•12/2018: We receive a CEDAR seed grant with Dr. Munks to study the earliest events in the failure of tumor-reactive T cells.
•10/2018: We are awarded a Collins Medical Trust grant!
•08/2018: Welcome to our new lab member Dr. Xiangnan Guan from Ohio State University.
•08/2018: Xia lab moves into the new Knight Cancer Research Building which brings multidisciplinary scientists together under one roof to accelerate collaborations.
•05/2018: Zheng is awarded a NIH career development grant! Congratulations!
•03/2018: We are awarded a grant from the Childhood Leukemia Foundation!
•01/2018: A Knight CEDAR grant is funded. We will work with Drs. Rozanov and Thompson for early breast cancer detection using TCR sequencing.
•01/2018: The paper with Adey Lab is accepted to Nature Biotechnology. Duanchen and Zheng are co-authors and contributed to the nonnegative matrix factorization based clustering for the single-cell DNA methylation data.
•01/2018: A manuscript is accepted to Nature Genetics. Zheng is a co-author.
•10/2017: Dr. Chaojie Wang from Ohio State University joins our team. Chaojie majors in Biochemistry. Welcome!
•09/2017: A manuscript is accepted to Elife. Zheng is a co-author.
•07/2017: Welcome to new Postdoctoral Researcher Duanchen Sun, who joined the group after receiving his PhD in Operations Research and Bioinformatics from Chinese Academy of Sciences.
•07/2017: Wes Horton joins the team as a Computational Biologist to provide bioinformatics support for our collaborators. Wes graduated from University of Oregon.
•05/2017: A manuscript is accepted to PLoS Genet. Zheng is a co-author.
•02/2017: A manuscript is accepted to Nucleic Acids Research. Zheng is a co-author.
•12/2016: A manuscript is accepted to Scientific Reports. Zheng is a co-author.
•11/2016: A manuscript is accepted to Science Advance. Zheng is a co-author.